Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2005-12-15 14:30:48 UTC |
---|
Update Date | 2021-09-14 15:46:10 UTC |
---|
HMDB ID | HMDB0001570 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Thymidine 3',5'-cyclic monophosphate |
---|
Description | Thymidine 3',5'-cyclic monophosphate is an intermediate in the pyrimidine metabolism. It is the product or substrate of the enzymes thymidylate synthase (EC 2.1.1.45), thymidylate synthase (FAD) (EC 2.1.1.148), thymidine kinase (EC 2.7.1.21), AMP-thymidine kinase (EC 2.7.1.114), ADP-thymidine kinase (EC 2.7.1.118), dTMP kinase (EC 2.7.4.9), T2-induced deoxynucleotide kinase (EC 2.7.4.12), 5'-nucleotidase (EC 3.1.3.5), Thymidylate 5'-phosphatase (EC 3.1.3.35), and ATP-diphosphatase (EC 3.6.1.5). |
---|
Structure | CC1=CN([C@H]2CC3OP(O)(=O)OCC3O2)C(=O)NC1=O InChI=1S/C10H13N2O7P/c1-5-3-12(10(14)11-9(5)13)8-2-6-7(18-8)4-17-20(15,16)19-6/h3,6-8H,2,4H2,1H3,(H,15,16)(H,11,13,14)/t6?,7?,8-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Thymidine 3',5'-cyclic monophosphoric acid | Generator | 3',5'-Cyclic thymidine monophosphate | HMDB | 3',5'-Cyclic TMP | HMDB | 4H-Furo[3,2-D]-1,3,2-dioxaphosphorin thymidine deriv. | HMDB | CTMP | HMDB | Cyclic 3',5'-dTMP | HMDB | Cyclic 3',5'-thymidylate | HMDB | Cyclic 3',5'-thymidylic acid | HMDB | Cyclic TMP | HMDB | Thymidine 3,5-cyclic monophosphate sodium salt | HMDB | Thymidine cyclic 3',5'-phosphate | HMDB | Thymidine cyclophosphate | HMDB | Thymidine phosphate (cyclic) | HMDB | 3',5'-Cyclic dTMP | HMDB | Cyclic 3',5'-thymidine monophosphate | HMDB |
|
---|
Chemical Formula | C10H13N2O7P |
---|
Average Molecular Weight | 304.1932 |
---|
Monoisotopic Molecular Weight | 304.046037292 |
---|
IUPAC Name | 1-[(6R)-2-hydroxy-2-oxo-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione |
---|
Traditional Name | 1-[(6R)-2-hydroxy-2-oxo-tetrahydro-4H-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methyl-3H-pyrimidine-2,4-dione |
---|
CAS Registry Number | 6453-60-7 |
---|
SMILES | CC1=CN([C@H]2CC3OP(O)(=O)OCC3O2)C(=O)NC1=O |
---|
InChI Identifier | InChI=1S/C10H13N2O7P/c1-5-3-12(10(14)11-9(5)13)8-2-6-7(18-8)4-17-20(15,16)19-6/h3,6-8H,2,4H2,1H3,(H,15,16)(H,11,13,14)/t6?,7?,8-/m1/s1 |
---|
InChI Key | QSJFDOVQWZVUQG-KAVNDROISA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrimidines and pyrimidine derivatives |
---|
Direct Parent | Pyrimidones |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidone
- Hydropyrimidine
- Organic phosphoric acid derivative
- Tetrahydrofuran
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Urea
- Oxacycle
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Thymidine 3',5'-cyclic monophosphate,1TMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C)OCC3O2)C(=O)[NH]C1=O | 2688.7 | Semi standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C)OCC3O2)C(=O)[NH]C1=O | 2565.5 | Standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C)OCC3O2)C(=O)[NH]C1=O | 3781.1 | Standard polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TMS,isomer #2 | CC1=CN([C@H]2CC3OP(=O)(O)OCC3O2)C(=O)N([Si](C)(C)C)C1=O | 2717.8 | Semi standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TMS,isomer #2 | CC1=CN([C@H]2CC3OP(=O)(O)OCC3O2)C(=O)N([Si](C)(C)C)C1=O | 2552.5 | Standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TMS,isomer #2 | CC1=CN([C@H]2CC3OP(=O)(O)OCC3O2)C(=O)N([Si](C)(C)C)C1=O | 4272.3 | Standard polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,2TMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C)OCC3O2)C(=O)N([Si](C)(C)C)C1=O | 2742.3 | Semi standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,2TMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C)OCC3O2)C(=O)N([Si](C)(C)C)C1=O | 2641.8 | Standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,2TMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C)OCC3O2)C(=O)N([Si](C)(C)C)C1=O | 3599.5 | Standard polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TBDMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C(C)(C)C)OCC3O2)C(=O)[NH]C1=O | 2926.0 | Semi standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TBDMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C(C)(C)C)OCC3O2)C(=O)[NH]C1=O | 2789.9 | Standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TBDMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C(C)(C)C)OCC3O2)C(=O)[NH]C1=O | 3962.9 | Standard polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TBDMS,isomer #2 | CC1=CN([C@H]2CC3OP(=O)(O)OCC3O2)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2946.9 | Semi standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TBDMS,isomer #2 | CC1=CN([C@H]2CC3OP(=O)(O)OCC3O2)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2784.8 | Standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,1TBDMS,isomer #2 | CC1=CN([C@H]2CC3OP(=O)(O)OCC3O2)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 4301.0 | Standard polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,2TBDMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C(C)(C)C)OCC3O2)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 3187.2 | Semi standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,2TBDMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C(C)(C)C)OCC3O2)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 3049.1 | Standard non polar | 33892256 | Thymidine 3',5'-cyclic monophosphate,2TBDMS,isomer #1 | CC1=CN([C@H]2CC3OP(=O)(O[Si](C)(C)C(C)(C)C)OCC3O2)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 3769.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Thymidine 3',5'-cyclic monophosphate GC-MS (Non-derivatized) - 70eV, Positive | splash10-004r-3920000000-fa087eafaf28aa10e71d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Thymidine 3',5'-cyclic monophosphate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 10V, Positive-QTOF | splash10-004i-0900000000-f2776d29a1a3861169b0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 20V, Positive-QTOF | splash10-004i-5900000000-1fe99e1c7b6b1795e591 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 40V, Positive-QTOF | splash10-055b-9500000000-6ffff7f8cd1316dc5fda | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 10V, Negative-QTOF | splash10-0udi-3259000000-9beab42162941871abf9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 20V, Negative-QTOF | splash10-004i-9241000000-c19bc3f132001e531528 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 40V, Negative-QTOF | splash10-004i-9000000000-421497715d00a39ac466 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 10V, Negative-QTOF | splash10-0udi-0009000000-3d6273a0f39a6bebcfcd | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 20V, Negative-QTOF | splash10-0ufr-5279000000-02bec4525b2cfc8dd947 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 40V, Negative-QTOF | splash10-002f-9460000000-cb76093e416c58997e8a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 10V, Positive-QTOF | splash10-0a4i-0009000000-286c2eb7e88f7c24dde3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 20V, Positive-QTOF | splash10-0a4i-0229000000-a97de09fdefe30a245bb | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Thymidine 3',5'-cyclic monophosphate 40V, Positive-QTOF | splash10-004i-4920000000-696c0224910c7b1cfb9c | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
General References | - Seno T, Ayusawa D, Shimizu K, Koyama H, Takeishi K, Hori T: Thymineless death and genetic events in mammalian cells. Basic Life Sci. 1985;31:241-63. [PubMed:3888175 ]
- Uckun FM: Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity. Arzneimittelforschung. 2006 Feb;56(2A):121-35. [PubMed:16570821 ]
- Uckun FM: Unmet challenges in HIV therapy and potential of stampidine. Arzneimittelforschung. 2006 Feb;56(2A):117-20. [PubMed:16570820 ]
- D'Cruz OJ, Uckun FM: Stampidine: a selective oculo-genital microbicide. J Antimicrob Chemother. 2005 Jul;56(1):10-9. Epub 2005 May 26. [PubMed:15919769 ]
- Venkatachalam TK, Goodman PA, Qazi S, D'Cruz O, Uckun FM: Rational drug design of multifunctional phosphoramidate substituted nucleoside analogs. Curr Pharm Des. 2004;10(15):1713-26. [PubMed:15180534 ]
- Gilchrest BA, Eller MS: DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc. 1999 Sep;4(1):35-40. [PubMed:10537005 ]
- Montgomery AB: Prophylaxis of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus type 1. Semin Respir Infect. 1989 Dec;4(4):311-7. [PubMed:2697054 ]
- Scanlon KJ, Kashani-Sabet M, Miyachi H: Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest. 1989;7(6):581-7. [PubMed:2698255 ]
- Jackson RC: Unresolved issues in the biochemical pharmacology of antifolates. NCI Monogr. 1987;(5):9-15. [PubMed:3323909 ]
- Rode W: [Thymidylate biosynthesis: its biological role and regulation in animal cells]. Postepy Biochem. 1986;32(4):401-20. [PubMed:3554195 ]
- Jia J: [Pneumocystis carinii pneumonia: a review]. Zhonghua Nei Ke Za Zhi. 1985 Mar;24(3):177-9. [PubMed:3891249 ]
- Shane B, Stokstad EL: Vitamin B12-folate interrelationships. Annu Rev Nutr. 1985;5:115-41. [PubMed:3927946 ]
- Kano Y, Sakamoto S, Miura Y, Takaku F: Disorders of cobalamin metabolism. Crit Rev Oncol Hematol. 1985;3(1):1-34. [PubMed:2861915 ]
- Seno T, Ayusawa D: [Cell life cycle and deoxyribonucleotide metabolism--molecular and genetic studies]. Tanpakushitsu Kakusan Koso. 1984 Mar;29(3):164-73. [PubMed:6371901 ]
- Shane B, Stokstad EL: The interrelationships among folate, vitamin B12, and methionine metabolism. Adv Nutr Res. 1983;5:133-70. [PubMed:6405588 ]
- Scott JM, Weir DG: Drug-induced megaloblastic change. Clin Haematol. 1980 Oct;9(3):587-606. [PubMed:6450011 ]
- Whitfield JF, MacManus JP, Rixon RH, Boynton AL, Youdale T, Swierenga S: The positive control of cell proliferation by the interplay on calcium ions and cyclic nucleotides. A review. In Vitro. 1976 Jan;12(1):1-18. [PubMed:172436 ]
|
---|